To learn more about the role of EGFR signaling and KCa3.1 in NSCLC cells, we generated partially erlotinib-resistant A549-3R cells by culturing them for ~ 9 weeks in the presence of 10 μmol/L erlotinib and 100 ng/ml EGF. This evidence concerns the gene EGF and non-small cell lung carcinoma.